SUN PHARMA ADV.RES.CO.LTD financial statements, including revenue, expenses, profit, and loss
The total revenue of SPARC for the last quarter is 128.60 M INR, and it's 23.50% lower compared to the previous quarter. The net income of Q2 24 is -1.07 B INR.